Admission Date: [**2178-3-16**]        Discharge Date: [**2178-3-20**]  Date of Birth:  [**2110-6-6**]        Sex:  M  Service:  OME   HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname 68742**] is a 67-year-old male with metastatic renal cell carcinoma, admitted to begin cycle 1, week 2 high-dose IL-2 on the select IL-2 protocol.
His oncologic history began in the winter of [**2175**], when he developed a right varicocele and hematuria with CT confirming a right renal mass.
On [**2176-1-20**], he underwent right laparoscopic nephrectomy with an 11-cm tumor noted, clear cell histology [**Last Name (un) 19076**] grade 2 with positive renal vein involvement, but all lymph nodes negative.
He was admitted on [**2178-3-9**] for week #2 of therapy, but a pericardial effusion was noted and he underwent a pericardial window via left mini-thoracotomy.
His echocardiogram today reveals a small pericardial effusion without tamponade, which appears loculated.
Chest x- ray reveals a small left pleural effusion with worsening left lower lobe opacity.
His shortness of breath had improved and he had no fevers or chills.
PAST MEDICAL HISTORY:  Hypertension, status post left adrenalectomy and splenectomy secondary to adenomyolipoma, in [**2169-7-5**], complicated by subdiaphragmatic abscess, hepatitis A as a teenager, ventral hernia repair, OA and gout.
ALLERGIES:  No known drug allergies.
PHYSICAL EXAMINATION:  GENERAL:  Elderly male in no acute distress.
LYMPH NODES: No cervical, supraclavicular, bilateral axillary or bilateral inguinal lymphadenopathy.
HEART:  Regular rate and rhythm, S1 and S2 with distant heart sounds.
CHEST:  Dull to percussion at the left base with absent breath sounds at the left base.
ABDOMEN: Round, obese, positive bowel sounds, soft, nontender, no hepatomegaly.
EXTREMITIES:  Trace lower extremity edema.
SKIN:  Patchy macular rash over bilateral extremities.
x14 potential doses.
He was ruled out for an MI by cardiac enzymes.
Blood cultures were sent to rule out infection, and he was maintained on vancomycin and cefepime.
He had followup blood cultures x2 sets on [**2178-3-19**], without evidence of growth.
DISCHARGE DIAGNOSES:  Metastatic renal cell carcinoma, status post cycle 1, week 2 high-dose IL-2 on the select IL-2 protocol, complicated by shock and hypoxia.
